About Section Bg

Our proprietary
data platform…

…uses a combination of a generic medicine ‘Moneyball’ strategy and AI/ML technology to forecast supply shortages and detect valuable products the rest of the market is unable to see. We then move quickly to execute on these insights with our established industry network to in-license or acquire overlooked, non-marketed applications at economical prices.